Streetbeat News

Products Services

AAPL

AMZN

DASH

GOOG

GOOGL

MSFT

UBER

DoorDash, Inc. (NYSE:DASH) is testing an AI-based chatbot, DashAI, to speed up food ordering and provide personalized restaurant recommendations. The move could give DoorDash a competitive edge in the food delivery market. Other tech giants like Apple, Alphabet, Microsoft, and Amazon have also been influenced by the AI trend.

Portfolio Pulse from Anusuya Lahiri

July 28, 2023 | 11:42 am

ABEO

Abeona Therapeutics has submitted the briefing package to the FDA for its pre-biologics license application meeting in August 2023. The application is for EB-101, an engineered cell therapy for Recessive Dystrophic Epidermolysis Bullosa.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 11:38 am

MNTS

Momentus Inc. (NASDAQ:MNTS), a U.S. commercial space company, has successfully deployed all customer payloads from its Vigoride-6 Orbital Service Vehicle launched in April 2023 aboard the SpaceX Transporter-7 mission. This marks the deployment of a total of 15 customer satellites over three missions conducted over the past year.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 11:36 am

The FDA has announced that GE Healthcare is recalling its Trusignal Spo2 Sensors due to issues that may reduce defibrillation energy and expose patients to unintended voltage.

Portfolio Pulse from Charles Gross

July 28, 2023 | 11:27 am

IMMP

MRK

Immutep Limited has announced the first patient has been enrolled and safely dosed in EFTISARC-NEO, the Phase II trial of eftilagimod alpha, in combination with radiotherapy and the anti-PD-1 therapy KEYTRUDA for patients with soft tissue sarcoma. This is the first chemotherapy-free trial to evaluate eftilagimod alpha in a neoadjuvant setting.

Portfolio Pulse from Charles Gross

July 28, 2023 | 11:26 am

AZN

IONS

Ionis Pharmaceuticals has expanded its existing collaboration with AstraZeneca to include exclusive rights for AstraZeneca to commercialize Eplontersen in Latin America. The two companies will continue to jointly develop and commercialize Eplontersen in the U.S.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 11:08 am

AAPL

Apple Inc. (NASDAQ:AAPL) is tightening its privacy measures on the App Store, requiring developers to provide justifications for using certain Apple APIs that could contribute to device fingerprinting. Developers will start receiving emails from Fall 2023 if they upload an app to App Store Connect that uses a 'required reason API' without adequately describing the purpose in its privacy manifest file. By Spring 2024, App Store Connect will no longer accept apps that fail to comply with this requirement. This move is part of Apple's push towards user privacy and data protection.

Portfolio Pulse from Sudhanshu Singh

July 28, 2023 | 11:07 am

OKYO

OKYO Pharma has announced a new agreement with Tufts Medical Center to conduct a 40-patient open-label trial evaluating the efficacy and safety of OK-101 in patients with neuropathic corneal pain. The investigational new drug is planned to be filed in Q4 of 2023.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 11:03 am

MRK

Merck announced that its Phase 3 KEYNOTE-756 trial met its primary endpoint of Pathological Complete Response (pCR) rate in patients with high-risk, early-stage ER+/HER2- breast cancer. This is the first positive Phase 3 study with an immunotherapy regimen to demonstrate a statistically significant improvement in pCR rate in the neoadjuvant setting for this patient population.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 10:46 am

BMWYY

MBGYY

A cargo ship carrying Mercedes-Benz Group (OTCPK: MBGYY) and BMW (OTCPK: BMWYY) vehicles caught fire off the coast of the Netherlands. The cause of the fire is not yet confirmed, but it could be due to one of the electric vehicles onboard. The ship was carrying nearly 3,800 automobiles, 25 of which were electric.

Portfolio Pulse from Anan Ashraf

July 28, 2023 | 10:44 am